Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 42,123 | 10,594 | 17,545 | 25,171 | 10,359 |
| Gross Profit | 42,123 | 10,594 | 17,545 | 25,171 | 10,359 |
| Operating Expenses | 72,323 | 76,249 | 57,162 | 38,992 | 26,700 |
| Operating Income | -30,200 | -65,655 | -39,617 | -13,821 | -16,341 |
| Interest Expense | 234 | 0 | 0 | 0 | 0 |
| Other Income | 2,226 | 1,398 | 910 | 121 | -87 |
| Pre-tax Income | -28,208 | -64,257 | -38,707 | -13,700 | -16,428 |
| Net Income Continuous | -28,208 | -64,257 | -38,707 | -13,700 | -16,428 |
| Net Income | $-28,208 | $-64,257 | $-38,707 | $-13,700 | $-16,428 |
| EPS Basic Total Ops | -16.25 | -69.75 | -80.50 | -270.50 | -335.75 |
| EPS Basic Continuous Ops | -16.21 | -69.75 | -80.49 | -270.32 | -335.81 |
| EPS Diluted Total Ops | -16.25 | -69.75 | -80.50 | -270.50 | -335.75 |
| EPS Diluted Continuous Ops | -16.21 | -69.75 | -80.49 | -270.32 | -335.81 |
| EPS Diluted Before Non-Recurring Items | -16.25 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-29,177 | $-64,694 | $-38,982 | $-13,166 | $-16,044 |